Successful Use of Anti-CD20 Monoclonal Antibody (Rituximab) for ABO-Incompatible Living-Related Liver Transplantation - Concepedia

Concepedia

Publication | Closed Access

Successful Use of Anti-CD20 Monoclonal Antibody (Rituximab) for ABO-Incompatible Living-Related Liver Transplantation

90

Citations

13

References

2004

Year

Masahiro Usuda, Keisei Fujimori, Nozomi Koyamada, Tatsuya Fukumori, Satoshi Sekiguchi, Naoki Kawagishi, Yorihiro Akamatsu, Yoshitaka Enomoto, Kazushige Satoh, Akira Satoh,

Transplantation

Abstract

Rituximab efficiently reduces anti-ABO antibody titer by selectively eliminating B cells and is safe and effective against humoral rejection after ABO-incompatible liver transplantation.

References

	Year	Citations

Page 1